Agrochemicals company Insecticides (India) announced Q3FY25 results Financial Highlights: Revenue from Operations for Q3FY25 remained stable at Rs 357.7 crore, similar to Rs 357.9 crore in Q3FY24. Gross Profit increased by 20% YoY to Rs 129.2 crore from Rs 108.0 crore, with Gross Profit Margin improving to 36.1% (vs. 30.2%). EBITDA grew by 19% YoY to Rs 30.9 crore from Rs 26.0 crore, with EBITDA Margin expanding to 8.6% from 7.3%. PAT saw a 42% YoY increase, reaching Rs 17.4 crore compared to Rs 12.3 crore in Q3FY24. Business Highlights: Robust growth in recent launches like Mission, Mission SC, Shinwa, Izuki in first nine months. B2B sales remain impacted with challenging macro market conditions. 10 new products launched in first nine months including patented latest technology products Launched Centran, a patented 9(3) insecticide with dual-action for paddy. It aims to boost productivity and support farmers' economic growth Torry Super an innovative 9(3) herbicide for maize which is based on SPF technology, developed by in-house R&D; team Tie up with BioPrime to brings Relieve, it is exclusive biological product for the Indian market, furthering efforts to provide sustainable solutions for Indian agriculture. Received Patent for IZUKI, a fungicide for paddy. This has been developed in technical collaboration with Nissan Chemical Corporation Japan Rajesh Aggarwal, MD of Insecticides (India) said: “We are excited to share our robust performance during current quarter with 42% growth in PAT. This is in line with the strategic framework established at start of the year focusing on profitable growth with higher share of Premium Products and improving its margins. The first nine months has been in line with expectations, driven by strong contributions from our premium product range, which now constitutes 62% of B2C revenue and significant improvements in our EBITDA margins. We are optimistic about the upcoming seasons, supported by favorable tailwinds such as a strong monsoon, increased reservoir levels, and enhanced crop sowing. Furthermore, government policies in latest Union Budget for increasing farmer income and thrust on increasing output for cotton, pulses etc. are expected to provide additional positive momentum. We are delighted to share that we have received an overwhelming response from market to our new launches providing latest technology and complete crop solution to the farmers. Our commitment to innovation remains steadfast as we continue to enhance our technology offerings for farmers. In Q2 FY25, we acquired Kaeros Research Private Limited aimed at securing supply chains and reducing costs through direct imports. Kaeros holds import licenses and vendor approvals, providing valuable benefits. The acquisition was executed at fair value and is accretive to shareholder value. The Company’s fully paid-up capital is Rs. 4.78 crores, with land assets situated in Shamli, Uttar Pradesh used for field trials. We remain committed to investing in cutting-edge technology, fostering innovation, and ensuring operational excellence to deliver sustainable, profitable growth. With a clear vision and a solid foundation, we are confident in our ability to generate lasting value for our stakeholders and build a promising future for our business.” Result PDF